Physician profile
Amit Sharma
NPI 1568516946
$6,647.62
in general payments reported to CMS, 2019-2025
27 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $220 · 2021: $378 · 2022: $957 · 2023: $431 · 2024: $3,089 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Consulting Fee: $2,000 · Travel and Lodging: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.76 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $615.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $2,000.00 | 2024 | |
| Abbott Laboratories | $973.77 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $736.76 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $628.72 | 2021-2023 | Intracept |
| Spinefrontier, INC. | $322.05 | 2025 | Sijfuse, Inspan, Nanofuse |
| Nuvasive, INC. | $235.24 | 2022 | |
| Painteq LLC | $225.40 | 2024 | Painteq |
| Medtronic USA, INC. | $221.57 | 2019 | |
| Medtronic, INC. | $188.84 | 2024-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Biotronik Nro, INC. | $151.62 | 2024-2025 | Prospera |
| Spineology INC. | $111.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $97.26 | 2019-2022 | |
| Averitas Pharma INC. | $95.61 | 2024 | Qutenza |
| Scilex Pharmaceuticals INC. | $86.41 | 2024 | |
| Spinal Simplicity, LLC | $82.15 | 2025 | Ha Minuteman G3-R |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $75.44 | 2022-2024 | |
| Stratus Medical, LLC | $66.90 | 2023 | Nimbus |
| Nevro Corp. | $64.01 | 2019-2023 | Senza |
| Nalu Medical, INC. | $57.70 | 2023 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $54.48 | 2023 | Mild Device Kit |
| Depuy Synthes Sales INC. | $43.13 | 2024 | Orthovisc |
| Vertex Pharmaceuticals Incorporated | $32.62 | 2025 | |
| Melinta Therapeutics, LLC | $25.79 | 2022 | |
| Arbor Pharmaceuticals, INC. | $21.73 | 2021 | |
| Si-Bone, INC. | $21.62 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.61 | 2024 | Relistor |
| Collegium Pharmaceutical, INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.